Abstract Search

ea0073aep665 | Thyroid | ECE2021

Could ultrasound characteristics guide us on the presence of malignancy in thyroid nodules with Bethesda III cytology?

Suset Dueñas Disotuar , Ana R. Romero LLuch , Navarro Elena

BackgroundThyroid nodules with indeterminate cytology represent a therapeutic challenge. The probability of malignancy had been established between 5 and 15%, but it varies among the published data. Nowadays we have molecular tests to help in therapeutic decisions, but they are not available at all centers leaving uncertainty regarding appropriate management.Objectives To know the percentage of malignan...

0 shares

ea0073pep9.8 | Presented ePosters 9: Endocrine-Related Cancer | ECE2021

Outcomes of a multicenter surveillance protocol in asymptomatic Succinate Dehydrogenase (SDH) B and C mutation carriers

Romero LLuch Ana R. , Disotuar Suset Dueñas , Tous Romero Marai C. , Fernández Peña J. Ignacio , Cuenca Cuenca J. Ignacio , Elena Navarro

IntroductionBased on the evidence available back then, in 2015 we developed a provincial multicenter protocol for screening and follow up of no-index patients with SDHB and SDHC mutations.Objectives1. To evaluate the performance of the protocol designed for the follow-up of asymptomatic SDHB and C carriers. 2. To describe the penetrance of manifestations associated with hereditary PGL-FEO syndromes type 3 and...

0 shares

Endocrine Abstracts

Could ultrasound characteristics guide us on the presence of malignancy in thyroid nodules with Bethesda III cytology?

Outcomes of a multicenter surveillance protocol in asymptomatic Succinate Dehydrogenase (SDH) B and C mutation carriers

BiosciAbstracts